The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years
The findings offer valuable insights into the relationship between B cells and immunotherapy in solid tumors. This study primarily unveils the current research hotspots concerning the role of B cells in immunotherapy, encompassing both fundamental research and clinical trials, as well as the accelerating emergence of an increasing number of B-cell-centric immunotherapies.
Authors
- Chengjie Li (ORCID: https://orcid.org/0000-0001-5602-6566)
- Shuofeng Li (ORCID: https://orcid.org/0000-0003-2747-9501)
- Bing Tian (ORCID: https://orcid.org/0000-0003-2446-4363)
- Haitao Zhao (ORCID: https://orcid.org/0000-0002-3444-8044)
- Nan Zhang (ORCID: https://orcid.org/0009-0005-1392-8689)
- Lijin Zhao (ORCID: https://orcid.org/0000-0002-7741-5074)
- Mingjian Piao (ORCID: https://orcid.org/0009-0005-4981-5942)
- Shuang-Yuan Kuang
- Jiongyuan Li
Institutions
- Zunyi Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Affiliated Hospital of Zunyi Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1007/s12672-025-03458-3
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China
- Guizhou Science and Technology Department
- Peking Union Medical College Hospital
- Chinese Society of Clinical Oncology